Ansaripour S

ORCID: 0000-0003-4795-4613 · 5 papers in corpus
rct 2026
Annals of medicine and surgery (2012) ·doi:10.1097/ms9.0000000000004704

OBJECTIVE: This study aims to determine whether pretreatment with gonadotropin-releasing hormone agonists (GnRHa) can improve clinical outcomes. TRIAL DESIGN AND METHODS: This single-blinded, noninferiority randomized clinical trial aimed …

rct 2024
Contraception and reproductive medicine ·doi:10.1186/s40834-024-00265-z

BACKGROUND: In the last decade, luteal-phase ovarian stimulation (LPOS) has been suggested as an alternative controlled ovarian stimulation (COS) protocol for in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) cycles mainly …

rct 2024
Contraception and reproductive medicine ·doi:10.1186/s40834-024-00304-9

BACKGROUND: Adenomyosis can lead to infertility and failure of in vitro fertilization. Limited evidence suggests that the use of long-term treatment with gonadotropin-releasing hormone (GnRH) agonists followed by frozen-thawed embryo transf…

rct 2022
International journal of fertility & sterility ·doi:10.22074/ijfs.2021.532311.1141

Few studies have so far been done about the role of follicle stimulating hormone (FSH) in final oocytematuration. However, none of these studies have been performed solely on normoresponder patients. This study aimedto determine whether ooc…

observational 2020
PloS one ·doi:10.1371/journal.pone.0231943

Patients diagnosed with polycystic ovary syndrome (PCOS) are at high risk of developing a myriad of endocrinologic and metabolic derailments. Moreover, PCOS is a leading cause of habitual abortion, also known as recurrent pregnancy loss (RP…